Suspected adverse events, 2012

descriptionPublicationkeyboard_double_arrow_right Article 01 Dec 2013 English Publisher:WileyJournal:Veterinary Record, volume 173, pages 573-576 (issn: 0042-4900, eissn: 2042-7670,

Copyright policy )

Authors: G, Davis; A, Rooney; S, Cooles; G, Evans;

doi: 10.1136/vr.f7381

pmid: 24337090

Suspected adverse events, 2012

- Summary
- Subjects
- Metrics

Abstract

Increase in serious adverse events Increase in reports involving products marketed under the Small Animal Exemption Scheme Decrease in injection site reactions These are some of the results from the surveillance work carried out by the pharmacovigilance unit at the Veterinary Medicines Directorate (VMD), as discussed by Giles Davis and colleagues

Related Organizations

Veterinary Medicines Directorate

Keywords

Veterinary Medicine, Product Surveillance, Postmarketing, Animals, Humans, Veterinary Drugs, United Kingdom

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	9
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average